Scientists: aspirin reduces the risk of cancer of the pancreas

American researchers conducted a study involving thousands of patients, which proved that regular use of aspirin significantly reduces the risk of pancreatic cancer. Of the thousands of volunteers at 362 man was pancreatic cancer, the others entered in the control group.

Scientists are interested in how often and in what dosage, subjects taking aspirin. In addition, we investigated habits and body mass index. Usually aspirin is taken in small doses to prevent heart disease, high doses of aspirin have anti-inflammatory effect.

According to a study, low-dose aspirin reduced the risk of developing pancreatic cancer by 48%. Interestingly, the longer people took aspirin, the risk was lower.

Scientists pay attention to the reverse side of the coin. Aspirin has side effects that cannot be forgotten.

Subscribe to new posts: